I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasma cell | 4 studies | 30% ± 12% | |
| epithelial cell | 4 studies | 30% ± 11% | |
| ciliated cell | 3 studies | 27% ± 6% | |
| goblet cell | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 4 studies | 30% ± 12% | |
| epithelial cell | 4 studies | 30% ± 11% | |
| ciliated cell | 3 studies | 27% ± 6% | |
| goblet cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of IFI27L1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 527.04 | 2639 / 2642 | 100% | 22.43 | 705 / 705 |
| uterus | 100% | 342.24 | 170 / 170 | 100% | 21.33 | 458 / 459 |
| ovary | 100% | 863.48 | 180 / 180 | 100% | 13.65 | 429 / 430 |
| skin | 100% | 360.52 | 1807 / 1809 | 100% | 16.22 | 471 / 472 |
| adrenal gland | 100% | 1360.07 | 258 / 258 | 100% | 27.28 | 229 / 230 |
| thymus | 100% | 293.44 | 650 / 653 | 100% | 12.52 | 603 / 605 |
| prostate | 100% | 245.19 | 244 / 245 | 100% | 13.71 | 500 / 502 |
| lung | 100% | 412.17 | 577 / 578 | 99% | 11.34 | 1143 / 1155 |
| kidney | 100% | 368.74 | 89 / 89 | 98% | 10.64 | 887 / 901 |
| breast | 100% | 381.17 | 459 / 459 | 98% | 12.37 | 1100 / 1118 |
| intestine | 100% | 339.83 | 966 / 966 | 98% | 11.21 | 517 / 527 |
| stomach | 100% | 300.28 | 359 / 359 | 98% | 8.59 | 279 / 286 |
| bladder | 100% | 195.43 | 21 / 21 | 96% | 11.74 | 482 / 504 |
| esophagus | 100% | 270.29 | 1444 / 1445 | 95% | 8.27 | 173 / 183 |
| pancreas | 95% | 153.32 | 311 / 328 | 99% | 12.83 | 177 / 178 |
| liver | 93% | 149.35 | 211 / 226 | 97% | 11.42 | 394 / 406 |
| adipose | 100% | 394.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.25 | 29 / 29 |
| spleen | 100% | 386.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.48 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.29 | 1 / 1 |
| blood vessel | 99% | 246.47 | 1316 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 246.30 | 791 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 301.44 | 841 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 20.62 | 78 / 80 |
| peripheral blood | 60% | 174.56 | 553 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0097190 | Biological process | apoptotic signaling pathway |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | IFI27L1 |
| Protein name | Interferon alpha-inducible protein 27-like protein 1 (Interferon-stimulated gene 12c protein) (ISG12(c)) (ISG12C) Interferon alpha inducible protein 27 like 1 (Interferon alpha-inducible protein 27-like protein 1) |
| Synonyms | FAM14B |
| Description | FUNCTION: Plays a role in the apoptotic process and has a pro-apoptotic activity. . |
| Accessions | ENST00000555341.5 G3V2F0 ENST00000393115.7 ENST00000626801.1 G3V3W3 G3V349 ENST00000629798.2 ENST00000554544.5 ENST00000611681.3 G3V585 ENST00000556381.5 ENST00000557066.5 ENST00000628436.2 G3V460 ENST00000557218.5 ENST00000629591.2 ENST00000625811.1 ENST00000627505.2 ENST00000553664.1 ENST00000554166.5 ENST00000554562.1 G3V248 ENST00000627939.2 ENST00000555523.6 ENST00000627570.2 Q96BM0 G3V4A1 ENST00000627633.2 |
